CNS Pharmaceuticals, Inc. (CNSP): Total Liabilities
$4.10M
As of 2025-12-31
$3.74M
As of 2026-06-30
-5.9%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $4.10M | +62.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $2.52M | -58.8% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $6.13M | +24.6% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $4.92M | +89.7% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $2.59M | n/c | 2023-03-31, Balance as of period end |
| 2020-12-31 | $1.91M | +512.7% | 2022-03-03, Balance as of period end |
| 2019-12-31 | $311.0K | -74.8% | 2021-02-12, Balance as of period end |
| 2018-12-31 | $1.23M | n/a | 2020-03-12, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | 2025-12-31 | $4.10M | +62.5% |
| GRI Bio, Inc. (GRI) | 2025-12-31 | $2.66M | +55.7% |
| Palatin Technologies Inc (PTN) | 2026-06-30 | $1.84M | -77.2% |
| IGC Pharma, Inc. (IGC) | 2025-03-31 | $2.42M | -6.4% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $968.0K | +8.2% |
| Revium Rx. (RVRC) | 2025-12-31 | $1.42M | +145.7% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $1.93M | -40.0% |
| GT Biopharma, Inc. (GTBP) | 2025-09-30 | $1.32M | n/a |
| ProMIS Neurosciences Inc. (PMN) | 2025-12-31 | $10.44M | +330.9% |
Compare CNSP, GRI, PTN, IGC side by side · Screen every company in Pharmaceutical Preparations ↗